Company · ABT
Abbott Laboratories
Name as listed on its exchange; filed with the SEC as ABBOTT LABORATORIES.
Nasdaq's symbol directory lists ABT on the New York Stock Exchange as “Abbott Laboratories Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($1.3M); insiders sold on 4 occasions ($47.3M); 4 planned-sale notices; 24 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 33, No. 31
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Robert B. Ford, CHAIRMAN AND CEO sold $46.2M
- Daniel J. Starks bought $927K
- Morrone Louis H., EXECUTIVE VICE PRESIDENT sold $643K
- Moreland Mary K, EXECUTIVE VICE PRESIDENT sold $406K
- Philip P. Boudreau, EVP AND CFO bought $201K
- John G. Stratton bought $174K
- MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER sold $3K
Every trade (7)
- SELLMoreland Mary K, EXECUTIVE VICE PRESIDENT sold $406K
- SELLMCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER sold $3K
- SELLRobert B. Ford, CHAIRMAN AND CEO sold $46.2M
- SELLMorrone Louis H., EXECUTIVE VICE PRESIDENT sold $643K
- BUYJohn G. Stratton bought $174K
- BUYDaniel J. Starks bought $927K
- BUYPhilip P. Boudreau, EVP AND CFO bought $201K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Mary K. Moreland $406K
- John A. McCoy, Jr. $3K
- Robert B. Ford $46.2M
- Louis H. Morrone $643K
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Pete Sessions (R-TX17): Sale $50,001 - $100,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Thomas H. Kean (R-NJ07): Sale $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Sale $1,001 - $15,000
- Mike Kelly (R-PA16): Sale $1,001 - $15,000
- Richard W. Allen (R-GA12): Sale $15,001 - $50,000
- Rick Larsen (D-WA02): Sale $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Josh Gottheimer (D-NJ05): Sale $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
- Richard W. Allen (R-GA12): Sale $15,001 - $50,000
- Alan Armstrong (R-OK): Sale (Full) $15,001 - $50,000
- Laura Friedman (D-CA30): Exchange $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Thomas H. Kean (R-NJ07): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
- Julia Letlow (R-LA05): Sale $1,001 - $15,000
- Byron Donalds (R-FL19): Sale $1,001 - $15,000
- Byron Donalds (R-FL19): Sale $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Oct 21, 2026
- Other events Oct 21, 2026
- Regulation FD disclosure; Other events Aug 20, 2026
- Results of operations and financial condition Jul 16, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.